Clinical trial
Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft…
NCT00373165 · Lower Saxony Center for Nephrology, Other · Completed
Key facts
| NCT number | NCT00373165 |
|---|---|
| Title | Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients |
| Official title | Open, Randomised Study Comparing Preemptive Therapy With Intravenous Ganciclovir With and Without Additional Oral Ganciclovir for CMV Prophylaxis in Immunosuppressed Renal Transplant Patients Receiving Monitoring of CMV Viral Load |
| Lead sponsor | Lower Saxony Center for Nephrology, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | DNA Virus Infection, Herpesviridae Infections, Cytomegalovirus Infection |
| Intervention type | Drug |
| Interventions | Ganciclovir |
| Enrollment | 150 |
| Start date | Aug 1, 2000 |
| Completion | Oct 1, 2003 |
| First posted | Sep 7, 2006 |
| Last update posted | Sep 13, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: